These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9950454)

  • 21. Heart-kidney interactions in ischemic syndromes.
    Andreotti F; Crea F; Conti E
    Circulation; 2004 Feb; 109(5):e31-2; author reply e31-2. PubMed ID: 14769693
    [No Abstract]   [Full Text] [Related]  

  • 22. Myocardial salvage through coronary collateral growth by granulocyte colony-stimulating factor in chronic coronary artery disease: a controlled randomized trial.
    Meier P; Gloekler S; de Marchi SF; Indermuehle A; Rutz T; Traupe T; Steck H; Vogel R; Seiler C
    Circulation; 2009 Oct; 120(14):1355-63. PubMed ID: 19770393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic uses of vitamin E in prevention of atherosclerosis.
    Swain RA; Kaplan-Machlis B
    Altern Med Rev; 1999 Dec; 4(6):414-23. PubMed ID: 10608914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do ACE inhibitors have a real role in coronary artery disease?
    Cardiovasc J S Afr; 2003; 14(3):156. PubMed ID: 12934579
    [No Abstract]   [Full Text] [Related]  

  • 25. [CHAOS [Cambridge Heart Antioxidant Study]].
    Niki E; Noguchi N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():448-51. PubMed ID: 11347112
    [No Abstract]   [Full Text] [Related]  

  • 26. [Acute coronary syndrome you can hear the prognosis].
    Füessl HS
    MMW Fortschr Med; 2004 Feb; 146(6):16. PubMed ID: 15035308
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of aspirin according to type of stable coronary artery disease: insights from a large international cohort.
    Bavry AA; Gong Y; Handberg EM; Cooper-DeHoff RM; Pepine CJ
    Am J Med; 2015 Feb; 128(2):137-43. PubMed ID: 25447610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abciximab and atherosclerotic heart disease: use in percutaneous coronary intervention, acute coronary syndromes and acute myocardial infarction.
    Gum PA; Lincoff AM
    Int J Clin Pract; 2003; 57(1):43-8. PubMed ID: 12587942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction.
    Rapola JM; Virtamo J; Ripatti S; Huttunen JK; Albanes D; Taylor PR; Heinonen OP
    Lancet; 1997 Jun; 349(9067):1715-20. PubMed ID: 9193380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of intensive lipid lowering on coronary atheroma and clinical outcome.
    Houslay ES; Sarma J; Uren NG
    Heart; 2007 Feb; 93(2):149-51. PubMed ID: 17035507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended ASCOT - lipid lowering (ASCOT-LLA) study shows positive results of atorvastatin.
    Cardiovasc J Afr; 2008; 19(1):49-51. PubMed ID: 18320090
    [No Abstract]   [Full Text] [Related]  

  • 32. [Coronary artery disease - definitions and epidemiology].
    Schoenenberger AW; Erne P
    Ther Umsch; 2009 Apr; 66(4):223-9. PubMed ID: 19358133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term stability of heart rate variability in chronic stable angina pectoris, and the impact of an acute myocardial infarction.
    Björkander I; Forslund L; Ericson M; Rehnqvist N; Hjemdahl P; Kahan T
    Clin Physiol Funct Imaging; 2009 May; 29(3):201-8. PubMed ID: 19254330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents in patients with coronary artery disease.
    Zhang F; Dong L; Qian J; Ge J
    Ann Med; 2011 Feb; 43(1):75-9. PubMed ID: 21171912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial.
    Toma M; Buller CE; Westerhout CM; Fu Y; O'Neill WW; Holmes DR; Hamm CW; Granger CB; Armstrong PW;
    Eur Heart J; 2010 Jul; 31(14):1701-7. PubMed ID: 20530505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Secondary prevention is of significance for prognosis in coronary disease].
    de Faire U
    Lakartidningen; 1998 Oct; 95(42):4588-90, 4593-4. PubMed ID: 9814011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
    Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML
    Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin E and retrolental fibroplasia in 1982.
    Phelps DL
    Pediatrics; 1982 Sep; 70(3):420-5. PubMed ID: 7050877
    [No Abstract]   [Full Text] [Related]  

  • 39. Life after CHARISMA.
    Bousser MG
    Int J Stroke; 2006 Aug; 1(3):167-8. PubMed ID: 18706041
    [No Abstract]   [Full Text] [Related]  

  • 40. Vitamin E and atherosclerosis.
    Hooper PL; Hooper JJ
    Prev Cardiol; 2004; 7(3):144. PubMed ID: 15334739
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.